Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 7 to 23

Exercise program for children and adolescents after cancer treatment

Official title: Effects of a Physical Activity Program On Cardiorespiratory Fitness in Children and Adolescents folloWing Acute cancER Treatment: a Randomized Controlled Trial

Run by Universität Duisburg-Essen · NCT04765020 · Data updated 2026-11-12

This study is testing if a 12-week exercise program can help children and teens feel stronger and healthier after finishing cancer treatment.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages7 Years to 23 Years
SexAll
Enrollment56 (estimated)
SponsorUniversität Duisburg-Essen
Academic / other
Locations1 site (Krefeld)
StatusRecruiting
StartedJune 21, 2021
Main results expectedDecember 2027
Study endsJune 2028
Registry record updatedMay 15, 2026
Trial IDNCT04765020 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and adolescents aged 7 to 23 who have completed acute cancer treatment and are receiving follow-up care.

Probably not a fit

Patients under 7 or over 23 years of age, or those with medical conditions that limit their ability to participate, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The POWER study is a two-arm exercise intervention designed for pediatric patients who have recently completed acute cancer treatment. It aims to assess the impact of a 12-week moderate to high-intensity exercise program on cardiorespiratory fitness in children and adolescents, starting six weeks post-treatment. Participants will be randomly assigned to either an intervention group, which receives supervised exercise sessions and personalized activity targets, or a control group that receives general exercise recommendations. The study will also evaluate additional performance markers and patient-reported outcomes related to quality of life and health.

Why it matters

Potential benefit: If successful, this program could significantly improve cardiorespiratory fitness and overall health outcomes for children and adolescents recovering from cancer.

How similar studies have gone: Other studies have shown positive outcomes with exercise interventions in pediatric oncology, suggesting this approach is promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children and adolescents between 7 and 23 years of age
* Completion of acute cancer treatment and receiving follow-up care in Krefeld (Helios Hospital Krefeld)
* 6 weeks post cancer-treatment
* Signed informed consent (Parents and Patient)

Exclusion Criteria:

* \<7 years of age, \>23 years of age
* Medical condition that limits participation in one of the study arms
* Inability to follow the training-protocol
* Inability to carry out the spiroergometry on a cycle ergometer

Where it's running

  • Helios Klinik Krefeld
    Krefeld, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.